Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Millen

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Psychopharmacology Bulletin|June 29, 2010
Signal detection and placebo response in schizophrenia: parallels with depressionCraig H Mallinckrodt, Lu Zhang, William R Prucka, et al.
Biological Psychiatry|April 20, 2015
Exploratory analysis for a targeted patient population responsive to the metabotropic glutamate 2/3 receptor agonist pomaglumetad methionil in schizophreniaBruce J Kinon, Brian A Millen, Lu Zhang, et al.
BMJ (Clinical Research Ed.)|March 24, 2011
Impact of reduction in working hours for doctors in training on postgraduate medical education and patients' outcomes: systematic reviewS R Moonesinghe, J Lowery, N Shahi, et al.
Therapeutic Innovation & Regulatory Science|September 22, 2018
Multipopulation Tailoring Clinical Trials: Design, Analysis, and Inference ConsiderationsBrian A Millen, Alex Dmitrienko, Sumithra J Mandrekar, et al.
Schizophrenia Research and Treatment|April 29, 2014
Pomaglumetad Methionil (LY2140023 Monohydrate) and Aripiprazole in Patients with Schizophrenia: A Phase 3, Multicenter, Double-Blind ComparisonDavid H Adams, Lu Zhang, Brian A Millen, et al.
Journal of Child and Adolescent Psychopharmacology|March 1, 2012
Comparison of long-term (at least 24 weeks) weight gain and metabolic changes between adolescents and adults treated with olanzapineLudmila A Kryzhanovskaya, Wen Xu, Brian A Millen, et al.
The Journal of Surgical Research|November 15, 2020
Evolving Role of Liver Resection in Selected Patients With Metastatic Breast CancerJanelle-Cheri A Millen, Alana Hofmann, Jose Wilson Mesquita-Neto, et al.
Cephalalgia : an International Journal of Headache|June 1, 2018
Efficacy and safety of galcanezumab for the prevention of episodic migraine: Results of the EVOLVE-2 Phase 3 randomized controlled clinical trialVladimir Skljarevski, Manjit Matharu, Brian A Millen, et al.
Vaccine|July 26, 2023
Re-evaluation of the risk of venous thromboembolism after COVID-19 vaccination using haematological criteriaRebecca J Shaw, Andrew J Doyle, Emily A Millen, et al.
Headache|November 12, 2019
Rapid Onset of Effect of Galcanezumab for the Prevention of Episodic Migraine: Analysis of the EVOLVE StudiesHolland C Detke, Brian A Millen, Qi Zhang, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Psychopharmacology Bulletin|June 29, 2010
Signal detection and placebo response in schizophrenia: parallels with depressionCraig H Mallinckrodt, Lu Zhang, William R Prucka, et al.
Biological Psychiatry|April 20, 2015
Exploratory analysis for a targeted patient population responsive to the metabotropic glutamate 2/3 receptor agonist pomaglumetad methionil in schizophreniaBruce J Kinon, Brian A Millen, Lu Zhang, et al.
BMJ (Clinical Research Ed.)|March 24, 2011
Impact of reduction in working hours for doctors in training on postgraduate medical education and patients' outcomes: systematic reviewS R Moonesinghe, J Lowery, N Shahi, et al.
Therapeutic Innovation & Regulatory Science|September 22, 2018
Multipopulation Tailoring Clinical Trials: Design, Analysis, and Inference ConsiderationsBrian A Millen, Alex Dmitrienko, Sumithra J Mandrekar, et al.
Schizophrenia Research and Treatment|April 29, 2014
Pomaglumetad Methionil (LY2140023 Monohydrate) and Aripiprazole in Patients with Schizophrenia: A Phase 3, Multicenter, Double-Blind ComparisonDavid H Adams, Lu Zhang, Brian A Millen, et al.
Journal of Child and Adolescent Psychopharmacology|March 1, 2012
Comparison of long-term (at least 24 weeks) weight gain and metabolic changes between adolescents and adults treated with olanzapineLudmila A Kryzhanovskaya, Wen Xu, Brian A Millen, et al.
The Journal of Surgical Research|November 15, 2020
Evolving Role of Liver Resection in Selected Patients With Metastatic Breast CancerJanelle-Cheri A Millen, Alana Hofmann, Jose Wilson Mesquita-Neto, et al.
Cephalalgia : an International Journal of Headache|June 1, 2018
Efficacy and safety of galcanezumab for the prevention of episodic migraine: Results of the EVOLVE-2 Phase 3 randomized controlled clinical trialVladimir Skljarevski, Manjit Matharu, Brian A Millen, et al.
Vaccine|July 26, 2023
Re-evaluation of the risk of venous thromboembolism after COVID-19 vaccination using haematological criteriaRebecca J Shaw, Andrew J Doyle, Emily A Millen, et al.
Headache|November 12, 2019
Rapid Onset of Effect of Galcanezumab for the Prevention of Episodic Migraine: Analysis of the EVOLVE StudiesHolland C Detke, Brian A Millen, Qi Zhang, et al.
Pageof 4